Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Cardiotrophin-1 granted FDA orphan designation for use in kidney transplantation

Oct. 22, 2014

Fispemifene licensed to Apricus Biosciences

Oct. 21, 2014

Topline results reported from phase IIa study of LPCN-1111

Oct. 14, 2014

Patient enrollment under way in phase II trial of VPI-2690B in diabetic nephropathy

Oct. 9, 2014

Scientists at Roche synthesize novel autotaxin inhibitors

Oct. 9, 2014

DiscoveryBioMed receives grant for ADPKD drug development

Oct. 8, 2014

Linagliptin as potential treatment for uremic calcification

Oct. 3, 2014

Dimerix Bioscience receives approval to begin phase II trial of DMX-200

Oct. 2, 2014

CB2 agonists show potential for the treatment of kidney disease

Sep. 9, 2014

FDA approves Keryx Biopharmaceuticals' ferric citrate

Sep. 8, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...